Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Trading Statement

10 Feb 2017 07:00

RNS Number : 5406W
S & U PLC
10 February 2017
Β 

Β 10th February 2017

Β 

Β 

S&U plc

("S&U", "the Company" or "the Group")

Β 

YEAR END TRADING UPDATE

Β 

Β 

S&U plc, the motor finance and specialist lender, today issues a trading update for the period from its Trading Statement of the 8th December 2016 to the Company's year-end on the 31st January 2017.

Β 

The Company is again pleased to announce that trading has remained strong and in line with market expectations; its final results will be announced on 28th March 2017.

Β 

Current Trading

Β 

Advantage Finance, our motor finance business, finished a record year very strongly. Cash collections in the period exceeded a buoyant 2016 by 31%, whilst both transaction numbers and loan advances comfortably beat last year. This year Advantage achieved 20,000 new transactions for the first time, beating the previous record by nearly 5,000 deals; it now has a record 43,000 live customers.

Β 

Loan quality remains good and, as reported in our last Trading Statement, is both stable and within our expectations. This fully justifies the additional Β£33million invested in the business in the year just ended.

Β 

Within the last quarter, Advantage has received confirmation of its full licence authorisation from the FCA and has continued to introduce further refinements to its renowned underwriting and book analysis capabilities.Β 

Β 

Aspen Bridging

Β 

As anticipated in December, our Aspen bridging finance operation has now received all necessary approvals, and we are pleased to announce it has now opened for business. We confidently expect a successful pilot over the next fifteen months.

Β 

Funding and Treasury

Β 

At the year end the Group has borrowings of Β£49m allowing good headroom within our total committed facilities of Β£85m. We anticipate concluding further loan facilities as our businesses require.

Β 

Dividend

Β 

The Group's current trading and future prospects have led to your Board approving a second interim dividend of 28p per ordinary share (2016: 23p). This will be payable on 17th March 2017 to holders on the share register on the 24th February 2017. Together with the first dividend paid in November of 24p per share this will total 52p per share against 43p last year and 36p two years ago. These increases are consistent with our aim of returning to twice covered dividends over time.

Β 

Β 

Β 

Β 

Commenting on the Group trading and outlook, Anthony Coombs, Chairman of S&U PLC said:

Β 

"Within a robust domestic economy, a stable regulatory environment and a competitive market, we are confident in the Group's ability to continue to grow at a consistent and sustainable rate, and in the shareholder value that implies."

For further information, please contact:

Β 

S&U plcΒ www.suplc.co.ukΒ 

Anthony Coombs, Chairman 0121 705 7777

Β 

Broker & Financial Advisor

Chris Hardie Arden Partners 0207 614 5917

Β 

Media and Investor Relations

Ged Brumby Smithfield 0207 903 0674

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTBLGDDISGBGRC
Date   Source Headline
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results
17th Jan 20222:39 pmRNSAppointment of non-executive director
17th Jan 20222:33 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSTrading Statement
7th Dec 20217:00 amRNSBlock Listing Application
23rd Nov 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
29th Oct 20219:46 amRNSDirector/PDMR Shareholding
6th Oct 20217:00 amRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSInterim Results
22nd Sep 20217:00 amRNSInvestor Presentation
10th Aug 20217:00 amRNSTrading Update and Notice of Results
23rd Jul 20214:50 pmRNSDirector/PDMR Shareholding
30th Jun 20214:02 pmRNSDirector/PDMR Shareholding
24th May 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
20th May 202110:00 amRNSResult of AGM
20th May 20217:00 amRNSAGM Statement and Trading Update
23rd Apr 20211:00 pmRNSAnnual Report and Accounts
16th Apr 20215:37 pmRNSDirector/PDMR Shareholding and Total Voting Rights
14th Apr 20219:54 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.